Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
ABIOMED (ABMD) to Report Q3 Earnings: What's in the Cards?
01:33pm, Tuesday, 26'th Jan 2021
The strong momentum of ABIOMED's (ABMD) Impella product line, both in Europe and Japan, is expected to have continued in the fiscal third quarter as well.
Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents
08:03am, Thursday, 07'th Jan 2021
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed's robust intellectual prope
Abiomed: Do Not Fear The Valuation
04:40pm, Sunday, 03'rd Jan 2021
Abiomed's AAA financials, including a clean balance sheet and world-class margins can justify a premium in its valuation. Discounting Abiomed's future free cash flows, we derive the stock's intrinsic
Abiomed to Present at the 39th Annual J.P. Morgan Healthcare Conference
07:00am, Tuesday, 29'th Dec 2020
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed to present at the 39th annual J.P. Morgan Healthcare conference.
Abiomed's (ABMD) ECMO Technology Completes Successful Treatment
07:32am, Wednesday, 23'rd Dec 2020
Abiomed (ABMD) successfully treats first two patients in the world with the help of its Breethe OXY-1 System.
First Patients, Including a COVID-19 Patient, Treated with Abiomed's Innovative ECMO Technology
08:05am, Monday, 21'st Dec 2020
DANVERS, Mass.--(BUSINESS WIRE)--The first two patients in the world have been treated with the Abiomed Breethe OXY-1 System, including a COVID-19 patient in respiratory failure.
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021
12:02pm, Friday, 18'th Dec 2020
Four large-cap MedTech stocks are currently flourishing on the back of several positive developments
Two Milestones Achieved Toward Small Bore Access with Impella
08:03am, Tuesday, 15'th Dec 2020
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the achievement of two milestones in the development of small bore access for the Impella heart pump. The Impella ECP heart pump has c
These 3 Medical Device Stocks Leave Biotech in the Dust
06:36am, Wednesday, 18'th Nov 2020
Biotech stocks simply can't match these reliable returns.
Is Abiomed Stock a Buy?
07:07am, Saturday, 07'th Nov 2020
It depends on whether or not the company's decelerating revenue growth is a symptom of larger problems.
Here's Why Abiomed Dropped Today
06:08pm, Thursday, 29'th Oct 2020
Revenue bounces back, but growth is still lacking.
Abiomed, Inc. (ABMD) CEO Mike Minogue on Q2 2021 Results - Earnings Call Transcript
04:47pm, Thursday, 29'th Oct 2020
Abiomed, Inc. (ABMD) CEO Mike Minogue on Q2 2021 Results - Earnings Call Transcript
First Patients Treated with the World's Smallest Heart Pump, the 9Fr Impella ECP
08:03am, Wednesday, 28'th Oct 2020
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pu
TCTコネクト発表のデータから、急性心筋梗塞に伴う心原性ショック（AMICS）に対するPCI前のImpella使用が特に女性患者で生存率向上につながると判明
12:00am, Friday, 23'rd Oct 2020
（ビジネスワイヤ） -- 急性心筋梗塞に伴う心原性ショック（AMICS）患者を対象とした2つの研究で、PCI前にImpellaを留置した場合、PCI後にImpellaを留置�
Capital Investment Advisory Services LLC Has $237,000 Stake in ABIOMED, Inc. (NASDAQ:ABMD)
08:04am, Thursday, 22'nd Oct 2020
Capital Investment Advisory Services LLC decreased its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 5.5% during the third quarter, according to the company in its most recent filing with the SEC.
